Clinical Trials and Research

Apr 15, 2026
Department of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001,…
Apr 06, 2026
Ngoe Samuel BakiaDepartment of Pharmaceutical Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon.Chetcha Bernard…
Apr 02, 2026
Gene therapy eliminated pain and improved blood counts in most patients with sickle cell disease in a major trial.New results from a clinical trial show promising…
Apr 01, 2026
Sickle cell disease is characterized by chronic hemolytic anemia and recurrent severe vaso-occlusive crises. Ristoglogene autogetemcel (risto-cel) includes…
Apr 01, 2026
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative…
Mar 26, 2026
Recent studies have reached opposing conclusions about whether clonal hematopoiesis (CH) is increased or decreased in patients with sickle cell disease (SCD). Given…
Mar 26, 2026
Through a project aimed at building empathy and understanding among clinicians about sickle cell disease (SCD)-related pain episodes, a team of nurses in Chicago…
Mar 25, 2026
Omolola Kafayat AwolopeDepartment of Medical Laboratory Science, Afe Babalola University, Ado Ekiti, Ekiti State, Nigeria.David Olufemi AdeboDepartment of Clinical…
Mar 23, 2026
Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are…
Mar 23, 2026
Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are…